Harmonic Discovery Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2021

Location

New York NY US

Primary Industry

Biotechnology

About

Based in New York, US, and founded in 2021 by its CEO Rayees Rahman and co-founders Jason Lee, and Marcel Patek, Harmonic Discovery Inc. operates as a drug discovery company that builds an integrated computational and experimental platform. In September 2022, Harmonic Discovery raised USD 8 million in seed funding led by Innovation Endeavors, with participation from other new investors Fifty Years, Y Combinator, Boom Capital Management, and Caffeinated Capital. An individual investor also participated in the round. Harmonic Discovery Inc. offers an integrated kinase drug discovery platform that leverages multiple layers of kinase biology to design kinase therapeutics. The company develops novel therapies across diseases such as cancer and autoimmune disorders by spanning multiple disciplines, including systems biology, cheminformatics, medicinal chemistry, and machine learning. The company plans to use the seed funding to scale up its lab operations, build proprietary chemical libraries and expand its leadership team in order to enhance its drug discovery platform and pipeline.

Current Investors

Innovation Endeavors, Y Combinator, Caffeinated Capital

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals, Medical Software

Website

http://www.harmonicdiscovery.com

Verticals

Artificial Intelligence, HealthTech

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.